Internal Medicine, Nephrology · Rio Piedras, PR
NPI
1811992712
Since 2005
Specialty
Internal Medicine, Nephrology
Code 207RN0300X
Group practices
2
Medicare group memberships
Hospitals
1
Hospital affiliations
Suite 205 Carr.21 #1785 Las Lomas, Hospital Metropolitano
Rio Piedras, PR, 00921
Phone (787) 781-8506
Groups this clinician bills Medicare through
Medicare paid, 2024
$23K
140 services
Medicare patients, 2024
32
Average age 66
Drug cost, 2024
$203K
2,084 prescriptions
Company payments, 2025
$821
From 8 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Deniz E Garcia-de la Rosa was code 99214 (office e&m - established), 24 times for 13 patients. In total Deniz E Garcia-de la Rosa billed 140 services in 9 codes, and Medicare paid $23K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2008-01-18.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 24 | 13 | $63.72 | $1,529 |
By year: 2022 $30K for 160 services; 2023 $23K for 153 services; 2024 $23K for 140 services.
Medicare prescription drug claims, 2024
In 2024, the drug Deniz E Garcia-de la Rosa prescribed most often to Medicare patients was Sevelamer Carbonate, with 295 prescriptions and refills. In total Deniz E Garcia-de la Rosa wrote 2,084 Medicare prescriptions that cost $203K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Sevelamer Carbonate Generic | 295 | 303 | 39 | $61K |
| Spironolactone Generic | 142 | 157 | 28 | $1,305 |
| Calcium Acetate Generic | 101 | 105 | 20 | $12K |
| Calcitriol Generic | 91 | 109 | 20 | $1,467 |
| Amlodipine Besylate Generic | 71 | 81 | 14 | $287 |
| Carvedilol Generic | 64 | 86 | 15 | $536 |
| Sodium Polystyrene Sulfonate Generic | 64 | 68 | 23 | $7,458 |
| Atorvastatin Calcium Generic | 61 | 101 | 16 | $457 |
| Midodrine Hcl Generic | 59 | 63 | 14 | $2,844 |
| Lokelma Sodium Zirconium Cyclosilicate | 53 | 54 | Under 11 | $26K |
| Allopurinol Generic | 48 | 68 | 12 | $343 |
| Famotidine Generic | 46 | 46 | 11 | $284 |
| Furosemide Generic | 40 | 56 | Under 11 | $216 |
| Nifedipine Er Nifedipine | 39 | 43 | Under 11 | $730 |
| Losartan Potassium Generic | 37 | 53 | Under 11 | $307 |
Brand drugs: 224 claims; generic drugs: 1,847 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Deniz E Garcia-de la Rosa $821 ($821 in general payments such as food, travel and fees) from 8 companies. The largest payer was CorMedix Inc. with $261.
| Company | Payments | Amount |
|---|---|---|
| CorMedix Inc. CRMD | 1 | $261 |
| NxStage Medical, Inc. | 1 | $171 |
| GlaxoSmithKline, LLC. GSK | 1 | $112 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. 4578.T | 1 | $100 |
| AstraZeneca Pharmaceuticals LP AZN | 2 | $67.51 |
| Bayer Puerto Rico Inc. BAYN.DE | 2 | $44.79 |
| Mallinckrodt Hospital Products Inc. | 1 | $40 |
| Vifor Pharma, Inc. | 1 | $25 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.